ASH Clinical News: Promising Cardiac and Renal Responses with NEOD001 in Patients with AL Amyloidosis

ash has 79 videos Subscribe Here

Description: Morie Gertz, MD, talks to ASH Clinical News about the positive data from a phase I/II trial of the monoclonal antibody NEOD001 – a potentially disease-modifying agent for patients with AL amyloidosis and persistent organ dysfunction.
Shared By : ash
Posted on : 12/16/15
Added : 4 years ago
Category : Other